JAMES W MIER, M.D.
Osteopathic Medicine at Brookline Ave, Boston, MA
License number
Massachusetts 46528
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
2
330 Brookline Ave, Boston, MA 02215
26 John St Apt #2, Brookline, MA 02446
26 John St Apt #2, Brookline, MA 02446
Phone
(617) 667-0430
Personal information
See more information about JAMES W MIER at radaris.comName
Address
Phone
26 John St #2, Brookline, MA 02446
26 John St #2, Brookline, MA 02446
26 John St, Brookline, MA 02446
Brookline, MA
Professional information
Associate Professor Of Medicine At Beth Israel Deaconess Medical Center
Position:
Associate Professor of Medicine at Beth Israel Deaconess Medical Center
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Beth Israel Deaconess Medical Center
-
Associate Professor of Medicine
James W Mier, Boston MA
Specialties:
Internal Medicine, Medical Oncology, Gynecology
Work:
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA 02215 New England Eye Center
750 Washington St, Boston, MA 02111
330 Brookline Ave, Boston, MA 02215 New England Eye Center
750 Washington St, Boston, MA 02111
Education:
Indiana University(1973)
Dr. James W Mier, Boston MA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Beth Israel Deacnss Medical Center ONC
330 Brookline Ave, Boston 02215
(617) 667-1921 (Phone)
330 Brookline Ave, Boston 02215
(617) 667-1921 (Phone)
Certifications:
Internal Medicine, 1976, Medical Oncology, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Beth Israel Deacnss Medical Center ONC
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Indiana University School Of Medicine
Graduated: 1973
Emory Affil Hosps
Graduated: 1974
Graduated: 1976
Nci
Graduated: 1980
Indiana University School Of Medicine
Graduated: 1973
Emory Affil Hosps
Graduated: 1974
Graduated: 1976
Nci
Graduated: 1980
Alk1 Antagonists And Their Uses In Treating Renal Cell Carcinoma
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 1, 2013
Appl. No.:
13/757672
Inventors:
Rupal S. BHATT - Roslindale MA, US
Ravindra Kumar - Acton MA, US
James W. Mier - Brookline MA, US
Robert Pearsall - Woburn MA, US
Matthew Sherman - Newton MA, US
Nicolas Solban - Brighton MA, US
Ravindra Kumar - Acton MA, US
James W. Mier - Brookline MA, US
Robert Pearsall - Woburn MA, US
Matthew Sherman - Newton MA, US
Nicolas Solban - Brighton MA, US
International Classification:
A61K 38/45, A61K 31/404, A61K 31/44, A61K 31/436, A61K 31/4439, A61K 31/4709, A61K 31/517, A61K 39/395, A61K 31/506
US Classification:
4241341, 424 945, 4241391
Abstract:
In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a ligand-binding portion of the extracellular domain of activin-like kinase I (ALK1) polypeptide may be used to inhibit tumor growth of renal cell carcinoma (RCC) in vivo. In additional aspects the disclosure relates to the insight that a polypeptide comprising a ligand-binding portion of the extracellular domain of ALK1 dramatically increases the ability of a standard of care receptor tyrosine kinase inhibitor to inhibit RCC tumor growth in vivo.